Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01384383
Recruitment Status : Terminated
First Posted : June 29, 2011
Last Update Posted : February 3, 2014
Sponsor:
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 2013
Actual Study Completion Date : June 2013
Certification/Extension First Submitted : November 26, 2013